IRIDEX Corporation (IRIX)

Revenue by Segment

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jan 3, 2026	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021	Dec 28, 2019	Dec 29, 2018	Dec 30, 2017	Dec 31, 2016
Ophthalmology	52.68M	48.67M	51.87M	56.97M	53.90M
Total	52.68M	48.67M	51.87M	56.97M	53.90M

Revenue by Geography

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jan 3, 2026	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021	Dec 28, 2019	Dec 29, 2018	Dec 30, 2017	Dec 31, 2016
United States	23.21M	22.69M	26.05M	29.18M	24.95M
Europe, Middle East and Africa	14.39M	11.82M	13.52M	13.80M	13.97M
Asia/Pacific Rim	12.95M	11.95M	10.23M	10.93M	12.44M
Americas Excluding the U.S.	2.12M	2.21M	2.06M	3.06M	2.54M
Total	52.68M	48.67M	51.87M	56.97M	53.90M

Data Source: S&P Global Market Intelligence Last updated: Apr 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error